dimethyldioctadecylammonium has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, TJ; Kong, W; Li, B; Liu, CL; Wang, P; Wang, YQ; Wu, H; Wu, JX; Xia, Q; Yu, B; Yu, XH; Zhang, HH; Zhang, LX | 1 |
| Farmer, JL; Kanar, MC; Prager, MD; Vanderzee, J | 1 |
2 other study(ies) available for dimethyldioctadecylammonium and Melanoma
| Article | Year |
|---|---|
Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; Cell Line; Cell Proliferation; Female; Humans; Inhibitor of Apoptosis Proteins; Lipid A; Melanoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Organoplatinum Compounds; Oxaliplatin; Quaternary Ammonium Compounds; Specific Pathogen-Free Organisms; Survivin; T-Lymphocyte Subsets | 2013 |
Effect of dimethyldioctadecylammonium bromide induced macrophages on malignant cell proliferation.
Topics: Adjuvants, Immunologic; Animals; Cell Division; Cytotoxicity, Immunologic; Humans; Leukemia L1210; Lipopolysaccharides; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms; Quaternary Ammonium Compounds | 1985 |